Search research articles
Contact Us
Filters
Showing results (341-350 of 422) with videos related to
Page
of 43
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 19, 2002
IAP Guidelines for the Surgical Management of Acute Pancreatitis
Waldemar Uhl, Andrew Warshaw, Clement Imrie, et al.
Annals of Surgery
|
September 8, 2023
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery
Salvatore Paiella, Erica Secchettin, Gabriella Lionetto, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
May 1, 2018
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results
Salvatore Paiella, Roberto Salvia, Matteo De Pastena, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2019
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
Rosalinda Trovato, Alessandra Fiore, Sara Sartori, et al.
JAMA Surgery
|
July 25, 2019
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Laura Maggino, Giuseppe Malleo, Giovanni Marchegiani, et al.
Annals of Surgery
|
July 20, 2016
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Antonio Pea, Jun Yu, Neda Rezaee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2013
Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity
Elizabeth Poplin, Harpreet Wasan, Lindsey Rolfe, et al.
Oncotarget
|
May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
Michele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
Frontiers in Nutrition
|
June 7, 2023
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis
Salvatore Paiella, Danila Azzolina, Ilaria Trestini, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 25, 2015
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer
Kyoichi Takaori, Claudio Bassi, Andrew Biankin, et al.
Page
of 43
Search research articles
Search
Showing results (341-350 of 422) with videos related to
Sort By:
Page
of 43
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 19, 2002
IAP Guidelines for the Surgical Management of Acute Pancreatitis
Waldemar Uhl, Andrew Warshaw, Clement Imrie, et al.
Annals of Surgery
|
September 8, 2023
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery
Salvatore Paiella, Erica Secchettin, Gabriella Lionetto, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
May 1, 2018
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results
Salvatore Paiella, Roberto Salvia, Matteo De Pastena, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2019
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
Rosalinda Trovato, Alessandra Fiore, Sara Sartori, et al.
JAMA Surgery
|
July 25, 2019
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Laura Maggino, Giuseppe Malleo, Giovanni Marchegiani, et al.
Annals of Surgery
|
July 20, 2016
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Antonio Pea, Jun Yu, Neda Rezaee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2013
Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity
Elizabeth Poplin, Harpreet Wasan, Lindsey Rolfe, et al.
Oncotarget
|
May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
Michele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
Frontiers in Nutrition
|
June 7, 2023
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis
Salvatore Paiella, Danila Azzolina, Ilaria Trestini, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 25, 2015
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer
Kyoichi Takaori, Claudio Bassi, Andrew Biankin, et al.
Page
of 43